Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ruggieri

Showing results (191-200 of 220) with videos related to

Pageof 22
Sort By:
Giornale Di Clinica Medica|February 1, 1981
[Hepatic lesions in drug addiction]P R Dal Monte, N D'Imperio, G Formica, et al.
Neurology|October 26, 1999
Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MSM Trojano, C Avolio, G M Liuzzi, et al.
Journal of Lipid Research|March 1, 1995
Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growthA Abe, N S Radin, J A Shayman, et al.
European Journal of Neurology|April 23, 2014
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosisR Tortelli, M Copetti, M Ruggieri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2005
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatmentC Avolio, M Filippi, C Tortorella, et al.
European Journal of Neurology|June 12, 2012
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progressionR Tortelli, M Ruggieri, R Cortese, et al.
Neuropediatrics|March 30, 2011
Acute disseminated encephalomyelitis: a long-term prospective study and meta-analysisP Pavone, M Pettoello-Mantovano, A Le Pira, et al.
Clinical Genetics|September 12, 2014
The natural history of spinal neurofibromatosis: a critical review of clinical and genetic featuresM Ruggieri, A Polizzi, A Spalice, et al.
Clinical and Experimental Immunology|June 6, 2023
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activityM Fornaro, F Girolamo, F Cacciapaglia, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]X Biardeau, X Biardeau, O Lam van Ba, et al.
Pageof 22

Showing results (191-200 of 220) with videos related to

Sort By:
Pageof 22
Giornale Di Clinica Medica|February 1, 1981
[Hepatic lesions in drug addiction]P R Dal Monte, N D'Imperio, G Formica, et al.
Neurology|October 26, 1999
Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MSM Trojano, C Avolio, G M Liuzzi, et al.
Journal of Lipid Research|March 1, 1995
Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growthA Abe, N S Radin, J A Shayman, et al.
European Journal of Neurology|April 23, 2014
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosisR Tortelli, M Copetti, M Ruggieri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2005
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatmentC Avolio, M Filippi, C Tortorella, et al.
European Journal of Neurology|June 12, 2012
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progressionR Tortelli, M Ruggieri, R Cortese, et al.
Neuropediatrics|March 30, 2011
Acute disseminated encephalomyelitis: a long-term prospective study and meta-analysisP Pavone, M Pettoello-Mantovano, A Le Pira, et al.
Clinical Genetics|September 12, 2014
The natural history of spinal neurofibromatosis: a critical review of clinical and genetic featuresM Ruggieri, A Polizzi, A Spalice, et al.
Clinical and Experimental Immunology|June 6, 2023
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activityM Fornaro, F Girolamo, F Cacciapaglia, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]X Biardeau, X Biardeau, O Lam van Ba, et al.
Pageof 22